Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. RIVULET MEDIA INC. (RIVU) Message Board

THE SHOCKING TRUTH ABOUT BMSN 90% of al

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 5066
Posted On: 06/27/2013 10:18:10 AM
Posted By: DarkKnight83



[b]THE SHOCKING TRUTH ABOUT BMSN[/b]




90% of all start up companies biotech or not reports -O- income. Why would they have a revenue stream with no product? Once they have a marketable FDA



approved product then they can attract big pharma to buy them out! I never heard of any start-up penny stock company making millions of dollars in



revenue with no product! There will be a drastic change in PPS this July as FDA response is expected to come any day now that will initiate clinical



trials on humans.



Click on the link below to see why biotech companies need to dilute and what operating expenses they have?



http://www.dataev.com/it-experts-blog/bid/290...kimp-on-IT





Lawsuits? All BMSN Lawsuit have been [b]resolved[/b]! Case close! [b]Not[/b] wanted for federal questioning! Those lawsuit were meaningless! C'mon a



shell company that has no asset's nor product try's to cash in on BMSN!! Lawsuits happen all the time in every company! Not all claims are legit!



Look at StarCity capital LLC. with no [b]executives or employees[/b]! BWhahahahahahaha!! StarCity capital was just looking for a quick payday!! Its



equilavent to some sueing Mcdonalds for coffee that's too hot when they clearly ordered hot coffee!! lmao




http://investing.businessweek.com/research/st...=222502242



(Most Recent- Settled) Lawsuit Filed April 12, 2013



1. On January 2, 2013, Starcity exercised its right to convert $17,000 of its debt into


103,030,303 shares of BMSN (the “Conversion Notice”). The Conversion Notice took


advantage of extraordinarily low public market prices of BMSN common stock, as was Starcity’s


right under the STA. The next day, on January 3, 2013, Defendants, as they were required to do,



Between January 2, 2013 and February 27, 2013, Defendants, with the intent to


prefer their own personal and other stockholders’ stock positions ahead of Starcity’s lawful


stockholder position in BMSN, and to the knowing detriment of Starcity, used false promises and


deception to trick Starcity into surrendering its Starcity BMSN Stock Certificate based on the


false promise that such shares promptly would be transmitted electronically to Starcity’s


brokerage account via DWAC. For weeks after Starcity surrendered its Starcity BMSN Stock


Certificate, and while the price of BMSN stock was trading at similar very low prices,


Defendants continuously and falsely reassured Starcity that such DWACtransmission would be


made promptly. All the while, Defendants, and each of them, knew that Defendants intended to


construe the surrendering of such Starcity ...ons ahead of Starcity’s lawful


stockholder position in BMSN.



NOW THAT THESE Starcity FOOLS SOLD ALL THEIR BMSN TICKETS UP WE GO! THAT WAS THE LAST LAWSUIT WHICH HAS BEEN RESOLVED!!


Here are the other two which OLD and RESOLVED!!!





2. SETTLEMENT AGREEMENT


Parties: BIO-MATRIX SCIENTIFIC GROUP, INC. | 18 KTTV, LLC | BIO-MATRIX SCIENTIFIC GROUP, INC


Document Date: 3/12/2013


Industry: Medical Equipment and Supplies


Sector: Healthcare


Governing Law ennsylvania



3. SETTLEMENT AGREEMENT


Parties: ENTEST BIOMEDICAL, INC. | 18 KTTV, LLC | ENTEST BIOMEDICAL, INC


Document Date: 3/12/2013


Industry: Biotechnology and Drugs


Sector: Healthcare


Governing Law ennsylvania



10K spells out lawsuit resolution in section 11



THESE LAWSUITS ARE SO BORING AND IRREVELANT TO FDA APPROVAL! EVERY COMPANY WITH A LEGIMATE SERVICE OR PRODUCT IS EXPOSED TO LAWSUITS! BIG DEAL!!


CASE RESOLVED!! IN ADDITION THEY ARE ALL OLD! YAWN!!



CLICK ON THE LINK BELOW!! [b]ALL LAWSUIT ARE RESOLVED!![/b] LOOK ON THE BOTTOM 8 & 9!!


http://agreements.realdealdocs.com/Settlement-Agreement/




CLICK ON THE LINK BELOW TO FIND OUT WHY [b]DILUTION ISN"T ALWAYS A BAD THING[/b]!!


http://blog.seedrs.com/2013/06/14/why-dilutio...bad-thing/


http://www.dummies.com/how-to/content/new-pen...r-bad.html



[b]When new penny stock share issues are a good thing:[/b]



Legal battles: Smaller companies often find themselves in costly legal battles with much bigger players. For example, many tech companies must go to



court to enforce patents rights. To pay legal fees, companies may issue shares for general working capital purposes. When the company is on the right



side of a legal battle, it can be beneficial for them and shareholders to dilute in order to litigate.





The O/S is maxed out!! Dilution is over!




Here is an example of Oustanding shares and its impact!



Comparison of stocks - shares outstanding:



Intel (INTC) -      5.52 billion shares outstanding



Texas Instruments (TXN) -   1.24 billion shares outstanding (23% of Intel's # of shares)



Analog Devices (ADI) -      297.69 million shares outstanding (5% of Intel)



STMicroelectronics (STM) -      878.32 million shares outstanding (16% of Intel)



Advanced Micro Devices (AMD) -      672.13 million shares outstanding (12% of Intel)



Share stability and volatility:  A greater number of shares outstanding can also support the claim that a company has greater price stability, given



that it takes many more shares traded to create a significant percentage movement in the stock.  Contrary to this, the stock with a much lower number of



outstanding shares, like ADI above, representing only 5% of Intel's total, could be more vulnerable to price manipulation, requiring much fewer shares



to be traded up or down to move the stock price.




These BMSN Short Numbers are ridiculous



http://otcshortreport.com/index.php?index=BMSN


http://www.shortanalytics.com/getshortchart.php?tsymbol=BMSN





Good evening!! BMSN Crew!! BMSN has accomplished so much and has even been featured on NBC NEWS!! Know what you hold! There is plenty of DD out there!



These shares are more precious than gold right now! Treat it as such and enjoy the ride north!! We have a strong chance of hitting .007 today!!


http://www.nbcnews.com/id/51786808#.UZFZQIy9KSM


(Link is expired due to NBC featured news time frame)



Just because a company hired an outside source for more exposure doesn't make it a P&D scam!! eg. FB, FNMA


http://stockpromoters.com/view-stock-promotio...ceHolderyy



%24Footer1%24Image2.x=12&ctl00%24ContentPlaceHolderyy%24Footer1%24Image2.y=11




[i]


Get in now or miss the chance of a life time here!![/i]




Check out the technical chart analysis on BMSN! Clearly the charts are BULLISH!!


http://bullwarriorstocks.com/index.php/post/b...-6-14-2013



Oh Lawd look at this short volume!! I'm getting excited just thinking about the gains!! Please cover!


http://otcshortreport.com/index.php?index=BMSN


http://www.shortanalytics.com/getshortchart.php?tsymbol=BMSN




[b]Oncology Innovations[/b]


Some of biggest innovations have been in the field of oncology. The actress Angelina Jolie recently became the new face of breast cancer, after



announcing that she’d had a double-mastectomy upon discovering that she carried a gene that predicts about a 60 percent chance of developing the



disease.



Thanks to the advances in genetic screening, drug developers also now look for genetic mutations in tumors that can explain why they grow and



metastasize, and create drugs to specifically target that aspect of the disease.



Surely BMSN will save lives and eliminate the budden of a mastectomy! Breast cancer gene silicensing technology will do just that!!



Bio-Matrix Scientific Group's Regen BioPharma Submits Response to FDA Questions Regarding HemaXellerate Clinical Program


http://finance.yahoo.com/news/bio-matrix-scie...00616.html





Lets just say that the FDA has 30days to respond which I highly doubt it would take that long cause they already have BMSN information filed on their



system! We should be hearing a verdict by Mid July the latest! But realisticly a response from FDA can come with 2-3 weeks considering that the response



is mailed!



"We are pleased with the responses that we have provided to the FDA and look forward to initiating our clinical trials," stated David Koos, Chairman and



CEO of Regen BioPharma. "Although it is possible that a second round of comments may be issued, we feel this process is extremely useful to creating a



clinical trial that is optimized for safety and detection of efficacy."



http://finance.yahoo.com/news/bio-matrix-scie...00616.html





This is not a 1 day flip! If your looking for that please exit left! There are plenty of BS pump and dumps out there! BMSN is a long term hold! The



clock for FDA response started JUNE 7, 2013! They have [b]30 days[/b] to respond back! So I say mid July - August



we should here a final verdict! I haven't seen any recent dilution! Just a lot of stupid trading and heavy manipulation!



For people who kept complaining about the time for [b]IND submission time frame[/b] please click the link below and your faith in BMSN will be restored!



On Feb 5, 2013 Regen BioPharma Files Investigational New Drug (IND) Application With FDA on HemaXellerate I(TM) Stem Cell Drug for Aplastic Anemia!



http://www.ucdmc.ucdavis.edu/clinicaltrials/IND/step4.html



This link is proof that the application as MAIL rather Electronic submission! In the link it clearly states that the application must be mailed with 3



copies of the entire submission! Which mean Koos wasn't hiding information or delaying! It takes time to get the application processed, filed then



issued a reference number (IND#) Koos is operating with urgency not to please investors but to put BMSN on the right track to success!




Here the proof that [b]eliminates[/b] all doubt!! Copy and paste this text into a search engine! I used google! >>>>>>>investigational new drug (ind)



application process<<<<<<<


Next look for a PDF link from the FDA! It should be the Third box down! And the link should be something like this:



www.fda.gov/downloads/.../reportsmanualsforms/forms....


Ok now download the form yourself! Scroll to the bottom of the form! If clearly has signature panel boxes as well as the panel where a FDA official



would give the application an IND#!!!


IND# issuance is clearly not like buy a gallon a milk at the supermarket where a receipt is given immediately! The FDA submission process is very slow



for a reason! We are dealing with human life here! Have patience investors, sit back and accumulate those cheap shares while they are still here! [b]



Last major run we had only took 1 week to reach from sub-penny level to almost .02 cents!! That's how fast BMSN moves!! We will have our day in the sun!




[/b]




Now that we know for sure that we are operating in FISCAL year! Things will be very interesting in the next 30 days!! Not long before BMSN HemaXellerate



receives IND status!! My honest advice BUY and HOLD!! THESE PRICES ARE GIFTS!!




[b]FOURTH QUARTER [/b]STARTS IN JULY AND GUESS WHATS ON THE AGENDA!![b] BOOOMM [/b]TIME!!





Breast Cancer Technology NEWS was annouced in FEB. which mean BMSN business plan is in fiscal quarter NOT calender! This Breast Cancer news was FIRST



Press Release: Bio-Matrix Scientific Group Inc. – Tue, Feb 26, 2013 10:12 AM!!! Click on the link Below and do the math yourself! FDA news can arrive at



any moment! I can't believe people are confused on this issue! BMSN is not trying to confused investors! All the info is clearly laid out in black and



white!



WHY WOULD MMs ALLOW THE PPS TO RISE SO SUDDENLY THINK ABOUT IT!



http://finance.yahoo.com/news/bio-matrix-rege...30212.html


http://finance.yahoo.com/q/h?s=BMSN&t=201...2:12-04:00



FISCAL NOT CALENDER!!!



Upcoming Milestones


Response to FDA questions: Q3 2013


Initiate HemaXellerate trial: Q4 2013


Complete HemaXellerate trial: Q4 2014-Q2 2015


In license Min technology: Q2 2013


File IND on Min technology: Q4 2013


Initiate clinical trial on Min technology: Q4 2013


Complete clinical trial on Min technology: Q4 2014-Q2 2015




Q1= OCT NOV DEC


Q2= JAN FEB MAR


Q3= APR MAY JUN


Q4= JUL AUG SEP



BMSN IS RIGHT ON SCHEDULE!! THIS EXPLAINS WHY THE PPS MOVED UP SO SUDDENLY IN JUNE! THIS IS A MAJOR CATLYST!! SECURE YOUR POSITIONS AND ENJOY THE RIDE


NORTH!!




8-K for BMSN (Gene Slilencing Cancer Technology)


On May 1, 2013 Dr. Wei Ping Min ("Min") entered into an agreement ("Agreement") whereby Min assigned to Regen BioPharma Inc. ("Regen") , a wholly owned



subsidiary of Bio-Matrix Scientific Group, Inc.("the Company") , all right, title and interest in US Patent # 8,389,708 as well as all Patent



applications from the same family corresponding to numbers PCT/CA2006/000984, CA2612200 and EP1898936.("Min IP")



http://biz.yahoo.com/e/130612/bmsn8-k.html




Some people here are forgetting about BMSN Business Model! There ultimate end goal is to sell the biotechnology off to Big Pharma! Even though there



business approach is to see a product through Phase 1 & 2 before this happens, this “sale can come at any time!” The more Koos works on the development



of these technologies such as HemaXellerate and the MIN breast cancer vaccine, the more attractive and promising it becomes to big Pharma! As investors



I wouldn't worry about funding because that can come at any moment!



OUR BUSINESS MODEL | REGEN BIOPHARMA, INC.


The Regen BioPharma business model is to take multiple stem cell therapeutics to and through the human "safety and signal of efficacy" stage (Phase I/II



clinical trials), followed by exit. The approach is a highly focused analysis of issued patents in regenerative medicine, identification and acquisition



of undervalued assets that have demonstrated proof of concept, and forming companies around these assets. Having assembled a core infrastructure



specialized in obtaining regulatory approval and executing clinical trials in cell therapy, we aim to act as a "superincubator" that within 1-2 years



grows technologies from laboratory to an asset ready for spin-off or sale to feed the pipeline of Big Pharma.



http://www.regenbiopharma.com/business-model.html





Davis Koos now controls all three entities: Bio-Matrix Scientific Group, Regen BioPharma, Entest BioMedical according to recent developments announced



in the 8-k release! [i]Merging these entities is only logical from a business stand point! [/i]



http://biz.yahoo.com/e/130531/bmsn8-k.html





BMSN has thus far stayed current with their filings and business timeline! Keep in mind investors that these future event are guides! Anything can



happen especially with the FDA at any given notice! Expect a sudden rise in PPS with no reason before that news hits the wire! Given 4 straight weeks of



a down trend BMSN is ready to burst out like a soda bottle being shaking up will all the wacky selling pressure! It will run hard and many will chase



the PPS fast with [b]900%[/b] plus gains! I don't know any investor or trader that likes chasing unless your the savvy one that has been accumulation


during the shouts of doom and gloom ; Sky is falling messages! This is obviously the bottom! I was hoping to get some in the .001s but that [b]will



never happen[/b]! The stock after weeks of churning has now become [b]BULLISH![/b] Mark this post BMSN will run hard!



http://www.americanbulls.com/SignalPage.aspx?...icker=BMSN




I'm very happy with my position! The real question to all the newbies, Are you satified with your share count when this reaches [b].05+[/b]



Last Major PR was featured on NBC website! When FDA news hits the wire it will be covered by everyone!


http://www.nbcnews.com/id/51786808#.UZFZQIy9KSM




[b]PSTI[/b] received orphan drug designation for aplastic anemia which is the same disease HemaXellerate is treating! Its only in due time before



HemaXellerate receives orphan drug designation!



http://regulatoryaffairs.pharmaceutical-busin...tus-220213





Look at the share price the CEO purchased at!! You don't have to worry about shares being dumped on investors with no agenda other than going into a



CEOs pocket, no employees, 1 trillion shares and no agenda!! BMSN is nothing like that! Its the real deal! Most of the shares purchased by the CEOs were



brought well over .50!! Have no worries investors!



http://www.openinsider.com/search?q=bmsn



[i]The key is to be patient and accumulate! That's how the PPS bounced to almost .02 in such a short time! Change your trading strategy on this one!




Everyone need to be on accord here! Unless you like chasing! To each his own...Happy Trading! GLTA!



(0)
(0)




RIVULET MEDIA INC. (RIVU) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us